Suppr超能文献

鼻内镜下经蝶窦切除无功能垂体大腺瘤的长期结果

Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas.

作者信息

Dallapiazza Robert F, Grober Yuval, Starke Robert M, Laws Edward R, Jane John A

机构信息

*University of Virginia Health System, Department of Neurosurgery, Charlottesville, Virginia; ‡Brigham and Women's Hospital, Pituitary/Neuroendocrine Center, Boston, Massachusetts.

出版信息

Neurosurgery. 2015 Jan;76(1):42-52; discussion 52-3. doi: 10.1227/NEU.0000000000000563.

Abstract

BACKGROUND

Several studies report early results of endoscopic endonasal transsphenoidal surgery; however, none discuss long-term outcome measures such as tumor recurrence rates and the need for additional surgical procedures.

OBJECTIVE

To discuss the long-term outcomes after endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary macroadenomas.

METHODS

This is a retrospective study. Patients were included only if they had at least 5 years of clinical and imaging follow-up after surgery.

RESULTS

Eighty patients met the study criteria. Grossly complete resection was achieved in 71% of patients. Knosp grade 0 to 2 tumors and tumor with volumes <10 cm were significantly more likely to have received a grossly complete resection. There were 7 recurrences (12%) in patients who had received grossly complete resections, with a mean time to recurrence of 53 months. Among the 23 patients who had subtotal resections, 11 (61%) progressed radiographically, and 3 (17%) had symptomatic progression. Knosp score, surgical and radiographic evidence of invasion, and preoperative visual deficits were predictive of recurrence in a univariate analysis, but Knosp grade was the only independent predictor in a multivariate analysis. Kaplan-Meier analysis projected a 10-year progression-free survival rate of 80% and 21% for patients with gross total resections and subtotal resections, respectively.

CONCLUSION

At the long-term follow-up, 12% of patients had recurrent tumors after grossly complete resection. Recurrent or residual tumors were treated with either repeat surgery or Gamma Knife radiosurgery. Rates of complete resection, postoperative surgical and endocrinological complications, and additional surgical procedures are similar to previously published reports after microscopic transsphenoidal surgery.

摘要

背景

多项研究报告了鼻内镜下经蝶窦手术的早期结果;然而,尚无研究讨论诸如肿瘤复发率和再次手术需求等长期预后指标。

目的

探讨鼻内镜下经蝶窦手术治疗无功能垂体大腺瘤的长期疗效。

方法

这是一项回顾性研究。仅纳入术后至少有5年临床及影像学随访资料的患者。

结果

80例患者符合研究标准。71%的患者实现了大体全切。Knosp 0至2级肿瘤以及体积<10 cm的肿瘤更有可能实现大体全切。接受大体全切的患者中有7例复发(12%),平均复发时间为53个月。在23例次全切除的患者中,11例(61%)影像学进展,3例(17%)有症状进展。单因素分析显示,Knosp评分、手术及影像学侵袭证据和术前视力缺损可预测复发,但多因素分析显示Knosp分级是唯一的独立预测因素。Kaplan-Meier分析显示,大体全切和次全切除患者的10年无进展生存率分别为80%和21%。

结论

长期随访发现,大体全切术后12%的患者出现肿瘤复发。复发性或残留性肿瘤采用再次手术或伽玛刀放射外科治疗。全切率、术后手术及内分泌并发症以及再次手术率与既往发表的显微镜下经蝶窦手术报告相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验